Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.47 CAD | -1.42% |
|
-4.93% | -12.15% |
Jun. 07 | Transcript : HLS Therapeutics Inc. - Shareholder/Analyst Call | |
May. 28 | HLS Therapeutics Notes Role of Pharmaceutical Support Programs on Persistence with Clozapine Treatment in Quebec Study | MT |
Evolution of the average Target Price on HLS Therapeutics Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
![Consensus](/images/consensus_flch.gif)
Consensus detail
Consensus revision (last 18 months)
Analysts covering HLS Therapeutics Inc.
Stifel GMP |
EPS Revisions
- Stock Market
- Equities
- HLS Stock
- Consensus HLS Therapeutics Inc.